Perrigo Company (NASDAQ:PRGO) - Perrigo Divests Generic Pharma Business For $1.55B To Altaris Capital
Perrigo Company Plc (NYSE: PRGO) has agreed to sell its Generic Rx Pharmaceuticals business to Altaris Capital Partners for $1.55 ...
Source: benzinga.com